Is this a piece of news regarding world politics, sports, business, or science and technology?
Biovail Backs 2004 Earnings on Strong Sales Pharmaceutical firm Biovail Corp. on Tuesday narrowed the scope of its full-year revenue forecast to the middle of its prior estimate range, but backed its earnings prediction - excluding charges - of \$1. 
